Korea Investment Corp
SRPT icon

Korea Investment Corp’s Sarepta Therapeutics SRPT Stock Holding History

Korea Investment Corp’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-146,841
Closed -$13.6M – 751
2021
Q3 		$13.6M Sell
146,841
-23,500
-14% -$1.81M 0.04% 308
2021
Q2 		$13.2M Sell
170,341
-20,500
-11% -$1.55M 0.04% 337
2021
Q1 		$14.2M Sell
190,841
-13,800
-7% -$1.27M 0.04% 300
2020
Q4 		$34.9M Buy
204,641
+18,500
+10% +$2.74M 0.1% 199
2020
Q3 		$26.1M Sell
186,141
-17,600
-9% -$2.67M 0.09% 206
2020
Q2 		$32.7M Buy
203,741
+4,000
+2% +$544K 0.12% 188
2020
Q1 		$19.5M Buy
199,741
+30,400
+18% +$3.47M 0.09% 216
2019
Q4 		$21.9M Buy
169,341
+6,600
+4% +$666K 0.08% 243
2019
Q3 		$12.3M Buy
162,741
+125,441
+336% +$14.8M 0.05% 326
2019
Q2 		$5.67M Sell
37,300
-3,400
-8% -$413K 0.02% 430
2019
Q1 		$4.85M Buy
40,700
+20,300
+100% +$2.61M 0.02% 460
2018
Q4 		$2.23M Hold
20,400
– – 0.01% 496
2018
Q3 		$3.29M Buy
+20,400
New +$2.79M 0.02% 480

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Korea Investment Corp's SRPT Position: Q4 2021 in Review

Korea Investment Corp sold out of Sarepta Therapeutics (SRPT) in Q4 2021, closing a stake of 146,841 shares — an estimated $13.6M sold.

Korea Investment Corp first reported a position in SRPT in Q3 2018 and held it in 13 quarters. The position peaked at $34.9M in Q4 2020. 343 funds tracked by Wall St. Rank hold SRPT as of Q4 2021.

  • Korea Investment Corp reported no remaining Sarepta Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Korea Investment Corp sold 146,841 Sarepta Therapeutics shares in Q4 2021, an estimated $13.6M.
  • Korea Investment Corp first reported a position in Sarepta Therapeutics in Q3 2018 and held it in 13 quarters.
  • Korea Investment Corp's Sarepta Therapeutics position peaked at $34.9M in Q4 2020.
  • 343 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2021.

Based on Korea Investment Corp's 13F filing for Q4 2021, filed 9 Feb 2022.